Business

FDA Clears Development Path for BTX 1801

FDA Clears Development Path for BTX 1801

articleBotanix Pharmaceuticals LimitedNovember 10, 20205/company/botanix-pharmaceuticals-ltd/news/fda-clears-development-path-for-btx-1801
FDA Clears Development Path for BTX 1801

About this update from Botanix Pharmaceuticals Limited

[{"type":"text","content":"Botanix Pharmaceuticals Ltd has released a press release. View Attachment","length":239,"tagName":"div"}]

More updates from Botanix Pharmaceuticals Limited